clinically for a variety of situations, including inflammatory disorders, specific cancers,
rheumatoid arthritis, and organ/tissue transplantation. However, glucocorticoid therapy is
also associated with additional complications, including steroid-induced diabetes. We
hypothesized that modification of the steroid backbone is one strategy to enhance the
therapeutic potential of GR activation. Toward this goal, two commercially unavailable …